GSKGLAXF
13F holders, Q1 2026 (March 31)2holders +1
1new positions
0sold out
$27.22avg. 13F price*
At the end of Q1 2026, 2 institutions reported holding GSK PLC (GLAXF) in their 13F filings, up 1 from Q4 2025. 1 opened new positions and 0 sold out. The largest holders were Aristotle Capital Management, LLC ($76.9M) and Generali Investments CEE, investicni spolecnost, a.s. ($1.0M).
- Company
- GSK PLC
- CUSIP
- G3910J179
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1.0M |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 38,314 shares bought and 181,153 shares sold, net −142,839 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Aristotle Capital Management, LLC | 0.16% | Reduce -6.0% | 2,824,721 | $76.9M |
| Generali Investments CEE, investicni spolecnost, a.s. | 0.05% | New | 38,314 | $1.0M |
"% of holder's portfolio" is GLAXF's weight in each manager's 13F, not the share of GSK PLC the manager owns.